2cureX prepares for market launch of IndiTreat™ in 2020 – international Chief Business Officer is recruited to lead the process
2cureX AB (Nasdaq First North: 2CUREX), a MedTech company that has developed the IndiTreat™ test that uniquely matches the effective combination therapy with the individual cancer patient, announces today the strengthening of its Management Team with Mr. Maarten van der Linden as Chief Business Officer (CBO).Prior to join 2cureX, Maarten van der Linden spent most of his career in the pharmaceutical and diagnostics industry, with a focus on commercialising products within the oncology field. Mr. Van der Linden was until recently Senior Director of Marketing for Europe Middle East and Africa (